Page last updated: 2024-10-17

aminocaproic acid and Leukemia, Myeloid

aminocaproic acid has been researched along with Leukemia, Myeloid in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CATTAN, A1
SCHWARZENBERG, L1
SCHNEIDER, M1
AMIEL, JL1
MATHE, G1

Other Studies

1 other study available for aminocaproic acid and Leukemia, Myeloid

ArticleYear
[TRIAL TREATMENT BY EPSILON-AMINOCAPROIC ACID OF PATIENTS WITH HEMORRHAGIC SYNDROMES, ESPECIALLY SYNDROMES RELATED TO A THROMBOCYTOPENIA].
    La Presse medicale, 1963, Oct-19, Volume: 71

    Topics: Aminocaproates; Aminocaproic Acid; Anemia; Anemia, Aplastic; Humans; Leukemia; Leukemia, Lymphoid; L

1963